A spatiotemporal release platform based on pH/ROS stimuli-responsive hydrogel in wound repairing

IF 10.5 1区 医学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Ye Wu , Yu Wang , Linyu Long , Cheng Hu , Qingquan Kong , Yunbing Wang
{"title":"A spatiotemporal release platform based on pH/ROS stimuli-responsive hydrogel in wound repairing","authors":"Ye Wu ,&nbsp;Yu Wang ,&nbsp;Linyu Long ,&nbsp;Cheng Hu ,&nbsp;Qingquan Kong ,&nbsp;Yunbing Wang","doi":"10.1016/j.jconrel.2021.11.027","DOIUrl":null,"url":null,"abstract":"<div><p><span>Fabricating injectable hydrogel with multifunctions that matchs the highly ordered healing process of skin regeneration has greatly desired in treatment of chronic diabetic wounds. Herein, a pH/reactive oxygen species (ROS) dual responsive injectable glycopeptide hydrogel based on phenylboronic acid-grafted oxidized </span>dextran<span><span> and caffeic acid-grafted ε-polylysine was constructed, which exhibited inherent antibacterial and antioxidant capacities<span>. The mangiferin<span> (MF) with the ability to promote angiogenesis was encapsulated into pH-responsive micelles (MIC). Subsequently, diclofenac </span></span></span>sodium (DS) with anti-inflammatory activities and MIC@MF were embedded into the hydrogel. The hydrogel possessed good biodegradability, stable rheological property and self-healing ability, and could realize the spatiotemporal delivery of DS and MF. The in vitro and in vivo data showed that the hydrogel was biocompatible with effective anti-infection, anti-oxidation and anti-inflammation at early stages, then further promoted angiogenesis and accelerated wound repairing. Collectively, this novel glycopeptide hydrogel provides a facile and effective strategy for chronic diabetic wound repairing.</span></p></div>","PeriodicalId":15450,"journal":{"name":"Journal of Controlled Release","volume":"341 ","pages":"Pages 147-165"},"PeriodicalIF":10.5000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"67","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Controlled Release","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168365921006222","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 67

Abstract

Fabricating injectable hydrogel with multifunctions that matchs the highly ordered healing process of skin regeneration has greatly desired in treatment of chronic diabetic wounds. Herein, a pH/reactive oxygen species (ROS) dual responsive injectable glycopeptide hydrogel based on phenylboronic acid-grafted oxidized dextran and caffeic acid-grafted ε-polylysine was constructed, which exhibited inherent antibacterial and antioxidant capacities. The mangiferin (MF) with the ability to promote angiogenesis was encapsulated into pH-responsive micelles (MIC). Subsequently, diclofenac sodium (DS) with anti-inflammatory activities and MIC@MF were embedded into the hydrogel. The hydrogel possessed good biodegradability, stable rheological property and self-healing ability, and could realize the spatiotemporal delivery of DS and MF. The in vitro and in vivo data showed that the hydrogel was biocompatible with effective anti-infection, anti-oxidation and anti-inflammation at early stages, then further promoted angiogenesis and accelerated wound repairing. Collectively, this novel glycopeptide hydrogel provides a facile and effective strategy for chronic diabetic wound repairing.

Abstract Image

基于pH/ROS刺激反应水凝胶的时空释放平台在伤口修复中的应用
制备与皮肤再生高度有序愈合过程相匹配的多功能可注射水凝胶是治疗慢性糖尿病伤口的迫切需要。本文以苯硼酸接枝氧化葡聚糖和咖啡酸接枝ε-聚lysine为原料,构建了pH/活性氧双响应的可注射糖肽水凝胶,该凝胶具有抗菌和抗氧化性能。将具有促进血管生成能力的芒果苷(MF)包被在ph响应胶束(MIC)中。随后,将具有抗炎活性和MIC@MF的双氯芬酸钠(DS)嵌入水凝胶中。该水凝胶具有良好的生物降解性、稳定的流变性和自愈能力,可实现DS和MF的时空递送。体外和体内实验结果表明,水凝胶具有良好的生物相容性,早期抗感染、抗氧化、抗炎症,进一步促进血管生成,加速伤口修复。总之,这种新型糖肽水凝胶为慢性糖尿病伤口修复提供了一种简单有效的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Controlled Release
Journal of Controlled Release 医学-化学综合
CiteScore
18.50
自引率
5.60%
发文量
700
审稿时长
39 days
期刊介绍: The Journal of Controlled Release (JCR) proudly serves as the Official Journal of the Controlled Release Society and the Japan Society of Drug Delivery System. Dedicated to the broad field of delivery science and technology, JCR publishes high-quality research articles covering drug delivery systems and all facets of formulations. This includes the physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development across pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries. Priority is given to manuscripts that contribute to the fundamental understanding of principles or demonstrate the advantages of novel technologies in terms of safety and efficacy over current clinical standards. JCR strives to be a leading platform for advancements in delivery science and technology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信